1 / 4

Microfluidic Immunoassay market

Microfluidic Immunoassay Market is expected to grow at a CAGR of 12.7% from 2019 to reach $2.01 billion by 2025

Trisha4
Download Presentation

Microfluidic Immunoassay market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Microfluidic Immunoassay market by Product type (Lab-on-chip, percent Analyzers, Reagents and Assay), generation, application (Cardiac, Troponin, BNP) - worldwide Forecast to 2025 • molecular reputation among antibody and antigen that permits for detection of molecules with excessive specificity and sensitivity. Immunoassays are being extensively used for the quantification of target molecules in lots of programs, which include proteomics, medical diagnostics, pharmaceutical research, and primary organic investigations. The immunoassay is one of the essential analytical techniques based totally on • significantly explored. mixture of microfluidics and immunoassays offers a promising platform for various sensitive and automated point-of-care (p.c) diagnostics. In recent years, the usage of microfluidic chips for immunoassay has been • analysis gadget, have shown promising consequences in immunosensor structures. Microfluidic immunosensors offer huge advantages over conventional immunoassay techniques, which includes a excessive surface-to-quantity ratio for green mass transport in immunoreactions, for that reason permitting for immediate evaluation; a miniaturized micro channel measurement to decrease the intake of samples and reagents; and automatic integration with other features, such as pumps, valves, detectors, and mixers to reap a point- of-care (%) goal. Microfluidic systems, additionally termed as lab-on-a-chip and the micro general • 12.7% from 2019 to reach $2.01 billion via 2025. Microfluidic immunoassay is swiftly developing enterprise with capability of improving patient health in low-aid settings. % tests are accomplished in vital-care settings, ambulatory centers, physician workplace laboratories, or at patient’s domestic. The % enterprise is growing at a faster pace because of demographic shift and want for excessive throughput prognosis in value effective manner. but, the various present percent gadgets need sample pre-treatment before engaging in the take a look at, produce variable effects, and offer both qualitative, semi-quantitative or negative quantitative check effects. This caused rising recognition on achieving specific and quantitative effects; and miniaturization of p.c devices. microfluidic structures (lab-on-a- chip) have attracted a awesome deal of interest as a miniaturized immunodiagnostic platform. major blessings of LOC include consumption of small volumes of reagents and sample; and transport of precise results with fast turnaround time. Global Microfluidic Immunoassay marketplace is predicted to grow at a CAGR of ??????????????????, ??????????????➦ https://www.meticulousresearch.com/download-sample-report/cp_id=5034 Key Players The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global microfluidic immunoassay market are Abaxis, Inc. (a subsidiary of Zoetis Inc.), NanÅ• mix, Inc., Abbott

  2. Laboratories, Koninklijke Philips N.V., Biosurfit SA, Micropoint Bioscience, Inc., Siloam Biosciences, NanoEnTek Inc., OPKO Health, Inc., and Quidel Corporation among others. Any Doubt, Enquire Here : https://www.meticulousresearch.com/enquire-before-buying/cp_id=5034 Scope of the Report: Market by Product Type •Lab-on-chip/microfluidic diagnostics oMicrofluidic Analyzers oMicrofluidic Cartridges •Other Quantifiable POC diagnostics oPOC Analyzers oReagents and Assays Market by Technology •Point of Care Lab on Chip Technology oElectrochemical LOC POC Technology oOptical POC LOC Technology •Non-Lab on Chip Point of Care Technology Market by Application •Cardiac Biomarker Detection oSingle Biomarker Assay ▪Troponin ▪Brain Natriuretic Peptide (BNP) ▪Other Cardiac Biomarkers oMultiplexed Panel Assay •Inflammatory Biomarker Detection •Other Biomarkers •Emerging Biomarkers Market by Geography •North America •U.S. •Canada •Europe •Germany •France

  3. •U.K. •Italy •Spain •Rest of Europe (RoE) •Asia-Pacific (APAC) oJapan oChina oIndia oRest of Asia-Pacific (RoAPAC) •Latin America •Middle East & Africa Key questions answered in the report- •How does the LOC/microfluidics diagnostics increase the efficiency and adoption of quantitative POC immunoassay diagnostics? •How are the leading players utilizing the advantages of LOC/microfluidics diagnostics in their products? •What factors are contributing to the frequent usage of cardiac biomarkers in various end users? •How does the adoption of cardiac biomarker differ from other application? •What are the top competitors in this market and what strategies do they employ to gain shares? •What factors are driving growth and which market segments have the most potential for revenue expansion over the forecast period? •What strategies should new companies look to enter this market use to compete effectively? •What are the major drivers, restraints, challenges, and opportunities, in the global microfluidic immunoassay market? •Who are the major players in various countries and what share of the market do they hold? •What are the geographical trends and high growth regions/countries? About Us : We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

  4. Through our mixed bag of research offerings – syndicated research, custom research, and analyst engagement — we enable smart decision making to enhance business performance for global organizations. Our focus is also on finding answers to the challenging questions that global business leaders face on a daily basis. Each year, we deliver more than 300 syndicate studies and 60+ consulting projects across eight industry verticals in 20+ geographic markets. ??????????????????, ??????????????? (Pages 194)??????????➦ https://www.meticulousresearch.com/Checkout/74264832 Contact: Mr. Khushal Bombe Meticulous Market Research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- sales@meticulousresearch.com

More Related